Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Asia Journal, 2024. Verfasst von Rajesh Jain.
Abstract (Originalsprache)
In this TOBGM study, Intervention started very late, with OGTT performed an average of 15.6 weeks. And this is why it results in a modest reduction in primary outcome in the immediate treatment arm (24.9% Vs. Control group (30.5%), adjusted risk reduction 5.6%. OGTT was performed in less than 14 weeks in 23.2% of Women only, and most of the women were beyond the 14th week at entry level in both the Intervention and control groups. Insulin and Metformin use was more in the Treatment arm than in the control arm, 58.1% vs. 41.4% and 23.6% Vs. 10.4%, respectively. Interestingly, more benefits were seen in less than the 14th week of pregnancy.
Zitieren
APA
Jain, R. (2024). Review of TOGOBM study. Diabetes Asia Journal. https://doi.org/10.62996/daj.30112024
Vancouver
Jain R. Review of TOGOBM study. Diabetes Asia Journal. 2024. doi:10.62996/daj.30112024
BibTeX
@article{Jain2024,
author = {Jain, Rajesh},
title = {Review of TOGOBM study},
journal = {Diabetes Asia Journal},
year = {2024},
doi = {10.62996/daj.30112024}
}
EUVIMED